{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "../sources/BEQ_2301_OVERALL_multi.pdf", "file_path": "../sources/BEQ_2301_OVERALL_multi.pdf", "total_pages": 113, "format": "PDF 1.7", "title": "Presentazione standard di PowerPoint", "author": "Key-Stone", "subject": "", "keywords": "\"country\": \"Europe\",\"year\": 2023,\"target\": \"clinic\"", "creator": "Microsoft\u00ae PowerPoint\u00ae per Microsoft 365", "producer": "Microsoft\u00ae PowerPoint\u00ae per Microsoft 365", "creationDate": "D:20230602170729+02'00'", "modDate": "D:20230602170729+02'00'", "trapped": ""}, "page_content": " in relation to the affordability and perceived value of different pharmaceutical company brands. the data appears to be extracted from a survey or study where participants were asked to categorize the brands into specific value categories. in the first bar graph titled \"very affordable,\" the percentage responses are as follows: dentsply sirona: 6% 3m: 7% gc america: 6% kerr: 5% ivoclar: 4% voco: 4% coltene: 2% align technology: 2% kulzer: 4% kauray noritake: 2% tokuyama: 4% ultrarent: 2% bisco: 1% the second bar graph titled \"ideal quality/price ratio,\" displays the following results: dentsply sirona: 9% 3m: 10% gc america: 8% kerr: 5% ivoclar: 4% voco: 2% coltene: 2% align technology: 2% kulzer: 2% kauray noritake: 2% tokuyama: 4% ultrarent: 2% bisco: 1% it's important to note that the responses are categorized into specific brand names, with some brands highlighted in red for", "type": "Document"}}